Dentist reveals how you can earn up to £150k - and what he's really thinking when he's looking in your mouth
Each Monday, our Money team speaks to someone from a different profession to discover what it's really like. This week we chat to James Davies, a specialist orthodontist at Quayside Orthodontics in Carmarthenshire and Pembrokeshire...
People think my job is... something they would not want to do. Looking in people's mouths all day!
What I'd say to them is... it's better than working with smelly feet.
One thing I'd change about the industry is... the NHS contract. Dentists used to be paid for what they did, now they are paid per course of treatment. In short, if you do one filling or 20 you get paid the same. This discourages the treatment of those in high need unless the dentist becomes a charity. What we have seen over the past 20 years is privatisation by stealth. Make the NHS contract so difficult to undertake profitably that dentists vote with their feet - then the government can blame the "greedy dentist".
Being able to build a quick rapport is vital... Working in people's mouths is an intrusive process, so being able to reduce anxieties and tensions over difficult, potentially painful procedures is key. Communication is the most important skill - manual dexterity is a close second to this.
Every dentist will have a small number of patients...who they would gladly pay to go elsewhere.
The biggest mistake I made with a patient was... is miscommunication. A larger lady entered the practice and I asked her "when she was due". To my embarrassment, she replied "I had the baby 12 weeks ago." Cringe!
Watching the complete life transformation of a patient... who has finished their course of treatment is the most rewarding thing. Often within orthodontics, patients walk in unwilling to smile and with low self-esteem. They can walk out beaming and overflowing with positivity into their new lives. I personally find treating teenagers is incredibly rewarding, they have lots of dreams and aspirations, and they help to keep me young.
Read more of this series:
Often our hands are tied... by NHS regulation. There is so much dentists can do to improve people's smiles, but there is an overly complex set of rules of what constitutes NHS and private (cosmetic) treatment.
A practice I worked at was bought out by a multinational... and I was left working for a company that put profits over patient care and treated everybody as a number. On the positive flip, it motivated me to set up my own practice to be everything they were not, and it has been a runaway success. Kindness and the personal touch cost nothing!
Salaries start at... £38,000 in year one, rising to about £100,000 in year five. With a specialism you can earn upwards of £150,000.
There is a huge amount of freedom to pick and choose your work schedule... as most dentists are self-employed and are contracted to a practice. I have always worked four days a week, which gives me a day to pursue other interests, be it DIY, gardening or learning Welsh.
My day begins at... around 8am with a bowl of cornflakes (something I think is grossly underrated). I always buy an i newspaper on my way to work and see my first patient by 9am. I tend to see 25 patients a day and try to fit a 5km run at lunchtime twice a week. My evenings are spent ferrying my children to various activities before retiring at 10pm.
When you're staring into someone's mouth... the mind does wonder. I think about things going on in the family, ambitions/dreams and how to strive to be a better person.
Dentistry in the UK is a five-year course... to attain a bachelor in dental science degree from one of 16 dental schools. It is usually an undergraduate degree, though graduate entry is available from Aberdeen and Preston. Upon graduation, you enter on a dental foundation programme within the NHS. This currently pays £38,472 a year. Most dentists can expect to earn around £60,000 to £100,000 in subsequent years. There are 13 specialisms within dentistry that dentists can choose to study and attain postgraduate qualifications. I undertook a career in orthodontics, which required a three-year post graduate degree.
I would hope to semi-retire at... 60. I am lucky enough to have a NHS pension - a defined benefit pension scheme underwritten by the government. For a dentist joining today, you will have to be 67. If I am enjoying it, which I hope I still am, I would happily work two days a week for as long as I can or am allowed!
If I had my time again I would have... slowed down and lived my life at a jog rather than a sprint. I would have worried less about the future and enjoyed the journey more rather than the destination.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
33 minutes ago
- Yahoo
The NHS truths the Left don't want you to hear
Until very recently, Health Secretary Wes Streeting tried to market himself as a radical health reformer, who is not afraid to poke sacred cows. While his reform-minded rhetoric always remained at a highly-abstract and general level, Streeting deserved some credit for it, because he did not have to do this. He had the courage to say things which he knew would rub some people up the wrong way, not least the Corbynite wing of his own party. Sadly, that brief period of NHS candour is now officially over. Streeting, the self-styled reformer, is no more. He and his colleagues have fully retreated into their comfort zone. During the recent local election campaign, Labour distributed a leaflet that showed a mock medical bill, and a doctor holding up a credit card reader. The message was clear: vote for us, because this is what the other lot want to do to you. On Twitter/X, Labour are now frequently posting dire warnings about the alleged evils of insurance-based healthcare systems. This is exactly that old-school NHS cultism which Streeting used to disavow until five minutes ago. It may work for him. The NHS may be falling apart, but the cult around is still going strong. In the eyes of its keenest defenders, the NHS can do no wrong. They have quietly dropped the old cliché about the NHS being 'the envy of the word', and replaced it with a slightly more subtle version, which goes something like this: Once upon a time, the NHS used to be the best healthcare system in the world. But then, from 2010 on, it was systematically defunded. It was deliberately run into the ground, so that it can be privatised more easily. A privatised system would mean luxury healthcare for the rich, and Wild West medicine for the poor. None of these claims are true. Let's have a look at each of them in turn. The NHS was never the best healthcare system in the world. The idea that it ever was can be traced back to a ranking compiled by the Commonwealth Fund, an American healthcare think tank, which relies on a very unusual methodology, in which medical outcomes only account for a fifth of the total score. This matters, because on medical outcomes, the NHS has always been one of the worst-performing healthcare systems in the developed world – as even the Commonwealth Fund study shows. There is no turning point after which the NHS's performance suddenly deteriorated. It was just never good in the first place. At the end of the 2010s, age-adjusted real NHS spending per capita was only marginally higher than it had been in the beginning of the decade. Put differently, the NHS budget only just about kept pace with population growth, population ageing, and inflation. This clearly constituted a slowdown in spending increases compared to the previous decade. But it does not constitute a 'defunding'. In any case: that period of relative spending restraint is already over again. The NHS budget was given a massive boost during the pandemic, which has only been partially reversed. Public healthcare spending in the UK stands at just under 9% of GDP: one of the highest levels in the world. Conspiracy theories about secret plans to privatise the NHS have been around for decades. I wrote a report on this three years ago, for which I went through the news archives, and I found warnings about the NHS's imminent demise from every year since 1980. But somehow, it never happens. The NHS remains an unusually state-centred system. Most healthcare systems, including tax-funded ones, use a mix of public, private for-profit and private non-profit providers. There are no plans – secret or otherwise – to privatise the NHS. More's the pity. Because there is nothing wrong with private healthcare systems. There are good examples of private, insurance-based healthcare systems, most notably in the Netherlands and Switzerland, which are nothing like the dreaded system of the US. These systems cover everybody: poor people are exempt from health insurance premiums and co-payments. Under these systems, rich and poor alike get faster access to medical treatment, and better medical outcomes, than they would on the NHS. The only thing these people don't get is a naff feel-good mythology around their health systems. Broaden your horizons with award-winning British journalism. Try The Telegraph free for 1 month with unlimited access to our award-winning website, exclusive app, money-saving offers and more.
Medscape
2 hours ago
- Medscape
Radiology Workforce Shortages Impacting Cancer Care
A chronic shortage of radiologists and oncologists is putting patients in the UK at risk, a new report found. The annual workforce census by the Royal College of Radiologists (RCR) warned that the safe delivery of NHS cancer care is becoming 'increasingly impossible' due to an escalating shortfall of doctors coupled with rising demand for care. In 2024, the UK had a 29% shortfall of clinical radiologists, with regional gaps ranging from 25% in Scotland to 32% in Wales. The workforce grew by 4.7% that year — less than in 2023, when it increased by 6.3%. The college forecasts the radiologist shortfall will reach 39% by 2029. Oncology Under Strain Clinical oncologists are also in short supply, with a current 15% gap expected to rise to 19% by 2029. This is despite a 5.4% increase in the workforce in 2024—the strongest growth since 2018. The RCR reported that 23% of cancer centres were experiencing recruitment freezes, making it harder to meet growing demand. Demand Continues to Outpace Capacity The shortages threaten the government's plans to cut waiting times and improve cancer outcomes. In 2024, demand for computerised tomography (CT) and magnetic resonance imaging (MRI) grew by 8%, but workforce growth did not keep pace. Every radiology leader surveyed last year reported delays to diagnostic scans caused by staff shortages. Nine in 10 radiology team leaders reported that patients were waiting longer to start treatment, while seven in 10 expressed concern that staff shortages were putting patient safety at risk – down slightly from 85% in 2023. Chronic problems such as workforce shortages, reporting backlogs, and staff vacancies remain too high, according to Dr Robin Proctor, the RCR's m edical director responsible for professional practice and clinical radiology. Consultants Leaving Earlier Staff retention is worsening, with experienced consultants leaving the NHS at younger ages. In 2024, the median age of consultant clinical radiologists leaving the NHS workforce was 50 – down from 56 in 2020. Four in five (79%) of leavers were under 60, and two in five (42%) were under 45. Clinical oncologists followed a similar trend. Their median exit age dropped to 54, from 57 in 2023 and 59 in 2022. Nearly 76% of leavers were under 60, and 26% were under 45. One consultant clinical oncologist told the college that delays in scans and treatment were resulting in missed or late cancer diagnoses. Some patients' conditions were deteriorating or reaching a stage where treatment was no longer possible. Changing Work Practices 'Working conditions and ways of working need to change if we are to address this problem and meet the growing demand for our expertise,' Proctor said. The RCR has called on the government to invest in training and recruitment. In 2024, the NHS spent an estimated £325 million on temporary radiology staff. The cost of outsourcing had doubled since before the COVID-19 pandemic and had surged by almost a quarter in the past year. The RCR estimated that increasing radiology trainee numbers by 50% could eliminate three-quarters of the current shortfall and save the NHS £460 million over the next 10 years. 'Patients are being failed by a chronic lack of radiologists and oncologists,' said RCR president Dr Katharine Halliday. 'The longer we delay action, the worse it gets,' she added.
Yahoo
2 hours ago
- Yahoo
Alzheimer's blood test ‘can accurately pick up early symptoms'
A new blood test for Alzheimer's disease can accurately detect people with early symptoms, research suggests. Experts from the Mayo Clinic in the US have provided further evidence that blood tests can work to accurately diagnose dementia, by examining two proteins in blood plasma. These proteins – amyloid beta 42/40 and p-tau217 – are associated with amyloid plaque build-up, which is a hallmark of Alzheimer's disease. Researchers found the blood test was highly accurate, with 95% sensitivity, which means it was 95% accurate in picking up people with memory problems, with very few cases missed. It was also 82% for specificity, which means it was also highly accurate in ruling out people without dementia. The study was carried out on more than 500 people in an outpatient memory clinic, meaning it is real-world data. The blood test has already been approved by the Food and Drug Administration regulator in the US. Dr Gregg Day, who led the study in the Alzheimer's and Dementia journal, said the test was as good as more invasive tests currently in use. 'Our study found that blood testing affirmed the diagnosis of Alzheimer's disease with 95% sensitivity and 82% specificity,' he said. 'When performed in the outpatient clinical setting, this is similar to the accuracy of cerebrospinal fluid biomarkers of the disease and is much more convenient and cost-effective.' Overall, researchers found that p-tau217 levels were higher in patients with Alzheimer's disease versus those without the disease. Dr Day said the next steps in the research were to evaluate blood-based testing in more diverse patient populations and people with early Alzheimer's who show no cognitive symptoms. Dr Richard Oakley, associate director for research and innovation at the Alzheimer's Society in the UK, said the results 'suggest this test is very accurate' and could be used alongside other tests and observations from a trained health professional. He added: 'This study shows how blood tests are making diagnosis of Alzheimer's disease quicker, easier and more accessible than ever before in a real-world setting. 'While focused on Alzheimer's disease, the test was evaluated in people with other types of dementias too, showing that it may help with differentiate causes of cognitive decline – though more research in diverse groups of individuals and in community-based setting is still needed. 'Currently diagnosis options in the UK are often slow, expensive and can be invasive, meaning thousands miss out on the benefits one can bring. 'It's great to see blood tests like this approved for clinical use in the US – we hope to see the same in the NHS, which is why we're part of the Blood Biomarker Challenge.' The Blood Biomarker Challenge is a multi-million-pound research programme supported by the Alzheimer's Society, Alzheimer's Research UK and the National Institute for Health and Care Research. Its goal is to bring blood tests for dementia diagnosis to the NHS by 2029. Dr Oakley said: 'Blood tests will be critical to accelerate diagnosis and give more people access to the care, support and treatments they desperately need faster than ever before. 'We must see long-term investment in the tools and workforce needed to ensure everyone living with dementia can get an early an accurate diagnosis, which is even more important with disease-modifying treatments on the horizon.' Dr Julia Dudley, head of research at Alzheimer's Research UK, said: 'We urgently need to improve how we diagnose dementia and it's great to see international research working towards this goal. 'Blood tests in this study look at p-tau217 and amyloid beta 42/40, and showed the tests offered high accuracy in confirming Alzheimer's disease. 'This study adds to the growing evidence that blood tests can detect the diseases that cause dementia in people with early memory and thinking problems. 'An important point to consider is that people taking part in research don't always reflect the full diversity of those affected by dementia, who might have additional conditions or other characteristics. 'That is why work is needed to understand whether these blood tests work in a real-world setting. 'In the UK, studies like the Blood Biomarker Challenge are helping to build this evidence. 'The study is testing blood tests, including p-tau217, in thousands of people from sites across the UK. 'This work will be a crucial part of making diagnosis easier and faster, which will bring us closer to a cure.'
